Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$16.30 USD
-0.62 (-3.66%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $16.28 -0.02 (-0.12%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Cash flow Statements
Fiscal Year End for Hims & Hers Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -23.55 | -65.68 | -107.66 | -3.05 | 1.15 |
Depreciation/Amortization & Depletion | 3.83 | 7.62 | 6.39 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | 20.82 | -14.20 | 3.45 | 4.01 | 0.47 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 72.38 | 45.72 | 63.41 | -1.74 | -1.86 |
Net Cash From Operating Activities | 73.48 | -26.53 | -34.41 | -0.78 | -0.24 |
Property & Equipment | -17.22 | -2.71 | -0.83 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -0.46 | -46.47 | 0.00 | 0.00 |
Investments | 14.39 | 42.40 | -104.79 | 0.33 | -201.25 |
Other Investing Activities | -9.27 | -4.53 | -4.18 | 0.00 | 0.00 |
Net Cash from Investing Activities | -12.11 | 34.70 | -156.27 | 0.33 | -201.25 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.62 | 3.42 | 253.89 | 0.00 | 207.28 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -14.10 | -36.55 | -18.85 | 0.00 | -4.21 |
Net Cash from Financing Activities | -11.48 | -33.13 | 235.04 | 0.00 | 203.00 |
Effect of Exchange Rate Changes | -0.01 | -0.05 | -0.07 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 49.89 | -25.01 | 44.29 | -0.45 | 1.51 |
Cash at Beginning of Period | 47.63 | 72.64 | 28.35 | 1.51 | 0.00 |
Cash at End of Period | 97.52 | 47.63 | 72.64 | 1.06 | 1.51 |
Diluted Net EPS | -0.11 | -0.32 | -0.58 | -0.89 | 0.08 |
Fiscal Year End for Hims & Hers Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 24.43 | 11.13 | -23.55 | -24.79 | -17.22 |
Depreciation/Amortization & Depletion | 4.36 | 1.92 | 3.83 | 2.82 | 1.98 |
Net Change from Assets/Liabilities | 5.82 | -7.30 | 20.82 | 19.96 | 7.61 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 44.82 | 20.09 | 72.38 | 53.51 | 33.94 |
Net Cash From Operating Activities | 79.43 | 25.84 | 73.48 | 51.50 | 26.31 |
Property & Equipment | -13.79 | -10.58 | -17.22 | -8.59 | -5.31 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 28.56 | 27.00 | 14.39 | -17.51 | 7.63 |
Other Investing Activities | -6.19 | -3.38 | -9.27 | -6.71 | -4.06 |
Net Cash from Investing Activities | 8.57 | 13.04 | -12.11 | -32.80 | -1.74 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -29.90 | -22.99 | 2.62 | 2.59 | 1.46 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -25.47 | -7.31 | -14.10 | -10.10 | -7.41 |
Net Cash from Financing Activities | -55.37 | -30.31 | -11.48 | -7.51 | -5.95 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | -0.01 | 0.04 | 0.03 |
Net Change In Cash & Equivalents | 32.63 | 8.57 | 49.89 | 11.22 | 18.65 |
Cash at Beginning of Period | 97.52 | 97.52 | 47.63 | 47.63 | 47.63 |
Cash at End of Period | 130.15 | 106.09 | 97.52 | 58.85 | 66.27 |
Diluted Net EPS | 0.06 | 0.05 | 0.01 | -0.04 | -0.03 |